Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second International Distribution Contract Signed

10 Sep 2020 07:30

RNS Number : 5960Y
Zoetic International PLC
10 September 2020
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information for the purposes of Article 7 under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.

 

 

Zoetic International plc

("Zoetic" or the "Company")

 

Second International Distribution Contract Signed

 

 

Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD company, is pleased to announce that it has signed its second international distribution contract, as well as continued progress with its core CBD business.

 

Highlights

 

● Executed a second international distribution agreement covering the distribution of the Company's Chill brand of tobacco alternative CBD products in over 15 markets across Europe

 

● Additional stocks of Chill brand smokeable products secured following significant demand

 

Agreement reached with major European distributor

 

Further to the announcement on 2 September 2020 that Zoetic was in final negotiations of an international distribution contract, the Company is pleased to announce that an agreement has been reached with a major new international distributor for its Chill brand of tobacco alternative CBD products (the "Agreement"). The Agreement will see the Company's premium CBD offering reach consumers in over 15 markets across the European Union, with thousands of stores making preparations to stock the Chill range. In a promising development, this physical footprint will be complemented by an established eCommerce presence which saw substantial revenue generated from vaping products alone during the last financial period.

 

The Agreement follows directly from the announcement that the Company had signed its first international distribution contract for the Chill range of products on 6 July 2020, illustrating that there is extensive interest and demand for the Company's products on a multinational level. The Company continues to identify and pursue new opportunities globally and is keen to sustain the rapid rate of growth that it has enjoyed so far.

 

Trevor Taylor, Co-CEO of Zoetic, commented, "We are delighted to have secured a further international distribution partner for the Chill brand. This agreement serves to affirm the quality and popularity that our products enjoy. Our new partner's 15 years of trading experience within the EU tobacco market will provide an excellent platform to enable the sale of our products to consumers across Europe."

 

Replenishment of stocks of Chill brand smokeable product range

 

Following significant demand for its Chill brand products, Zoetic is pleased to have restocked its range of tobacco alternative CBD smokes online. With hemp, calm and mint varieties now back in stock, the Company will focus on continuing to grow its market share of its top-quality, USDA certified organic products.

 

Via its Chill brand, the Company believes it has the market's only THC-free, nicotine-free, CBD smokes. The Company is very pleased with the demand for its products, which is matched by the continual growth in popularity of the CBD chewable pouch market and ever-expanding interest in the Company's range of mint smokes which are continuing to benefit from the regulation of tobacco-based menthol cigarettes, which are now banned in Brazil, Canada, Ethiopia, Turkey, Moldova, the European Union and the United Kingdom.

 

The Company expects to launch with the US distributors over the next few months whilst the groundwork and logistics for the international distributors is finalised. The Company hopes to have sales in non-US markets for the Chill brand before the end of 2020.

 

Antonio Russo, Co-CEO of Zoetic, commented, "The depletion of our Chill brand stocks stands testament to the high regard in which our products are held. We are extremely happy to be returning Chill brand smokes to the pockets of consumers across our core US market and will continue to lead the way in the development and distribution of quality CBD products."

 

Trevor Taylor, Co-CEO of Zoetic, commented, "We knew our smokable line was going to be a big hit and are pleased to get our inventories built up ahead of the rollout of our larger retail launch, both in the US and internationally."

 

ENDS

 

Enquiries

 

Zoetic International plc c/o IFC Advisory

Trevor Taylor, Co-CEO

 

Allenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656

Nick Harriss / Nick Naylor (Corporate Finance)

Guy McDougall (Equity Sales)

 

IFC Advisory Ltd (Financial PR and IR) +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTEAKNEFFLEEEA
Date   Source Headline
25th Jun 20204:00 pmRNSHolding(s) in Company
24th Jun 20203:00 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSHolding(s) in Company
15th Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSSubscription for Equity
1st Jun 20207:00 amRNSNew Distribution Agreement and Trading Update
29th May 20207:00 amRNSFiling of Patents
27th May 20207:00 amRNSSale of DTU Interest and Kansas Nitrogen Assets
15th May 20207:00 amRNSTrading Update
11th May 20203:36 pmRNSHolding(s) in Company
6th May 20202:34 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSBoard and Strategy Changes, and Trading Update
3rd Apr 20207:00 amRNSIssue of Equity
1st Apr 20207:00 amRNSCOVID-19 Update
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSIssue of Equity
20th Mar 20207:00 amRNSCOVID-19 Update
5th Mar 20207:00 amRNSOperational update
12th Feb 20207:00 amRNSSubscription to raise £0.39 million
5th Feb 20207:00 amRNSTrading Update
23rd Dec 20197:00 amRNSInterim Results
16th Dec 20197:00 amRNSSettlement of Diversion Debt & Notice of Results
28th Nov 20197:00 amRNSResult of General Meeting
25th Nov 20197:00 amRNSTrading Update
14th Nov 20199:19 amRNSIssue of Equity
13th Nov 20192:06 pmRNSSecond Price Monitoring Extn
13th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSListing on the OTC
8th Nov 20199:01 amRNSIssue of Equity
7th Nov 20197:00 amRNSNotice of General Meeting
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
29th Oct 20194:42 pmRNSSecond Price Monitoring Extn
29th Oct 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20197:00 amRNSIssue of Shares
18th Oct 201911:05 amRNSSecond Price Monitoring Extn
18th Oct 201911:00 amRNSPrice Monitoring Extension
8th Oct 20197:00 amRNSAdoption of new share option scheme
4th Oct 20197:00 amRNSTrading Update
17th Sep 20197:00 amRNSDirectorate Change
12th Sep 201912:30 pmRNSDirector/PDMR Shareholding
9th Sep 201911:15 amRNSChange of Name
6th Sep 201910:30 amRNSDirector/PDMR Shareholding
4th Sep 201911:05 amRNSSecond Price Monitoring Extn
4th Sep 201911:00 amRNSPrice Monitoring Extension
4th Sep 20197:00 amRNSDirectorate Change
30th Aug 20194:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.